DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
-9.26%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$321M
AUM Growth
+$321M
Cap. Flow
-$3.96M
Cap. Flow %
-1.23%
Top 10 Hldgs %
50.52%
Holding
83
New
10
Increased
22
Reduced
13
Closed
8

Top Buys

1
CYTK icon
Cytokinetics
CYTK
$4.32M
2
TSVT
2seventy bio
TSVT
$3.73M
3
AXGN icon
Axogen
AXGN
$3.02M
4
MRUS icon
Merus
MRUS
$2.36M
5
TNDM icon
Tandem Diabetes Care
TNDM
$2.3M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$24.1M
2
SAGE
Sage Therapeutics
SAGE
$8.48M
3
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$5.93M
4
LYRA icon
Lyra Therapeutics
LYRA
$1.48M
5
RVMD icon
Revolution Medicines
RVMD
$1.08M

Sector Composition

1 Healthcare 82.12%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MGNX icon
51
MacroGenics
MGNX
$121M
$1.2M 0.37%
+258,496
New +$1.2M
CGEM icon
52
Cullinan Oncology
CGEM
$456M
$1.15M 0.36%
+127,284
New +$1.15M
ACET icon
53
Adicet Bio
ACET
$60.8M
$1.09M 0.34%
797,054
– –
ITOS
54
DELISTED
iTeos Therapeutics
ITOS
$1.08M 0.34%
98,560
– –
SYRS
55
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.05M 0.33%
265,878
– –
STRO icon
56
Sutro Biopharma
STRO
$85.6M
$982K 0.31%
283,079
+40,300
+17% +$140K
MRSN icon
57
Mersana Therapeutics
MRSN
$34.8M
$932K 0.29%
734,038
-76,807
-9% -$97.5K
VIGL
58
DELISTED
Vigil Neuroscience
VIGL
$929K 0.29%
172,308
– –
BHVN icon
59
Biohaven
BHVN
$1.71B
$910K 0.28%
35,000
+13,887
+66% +$361K
IMVT icon
60
Immunovant
IMVT
$2.91B
$864K 0.27%
+22,500
New +$864K
ACRV icon
61
Acrivon Therapeutics
ACRV
$42.2M
$735K 0.23%
76,852
– –
NVRO
62
DELISTED
NEVRO CORP.
NVRO
$538K 0.17%
28,000
– –
STIM icon
63
Neuronetics
STIM
$216M
$424K 0.13%
313,717
– –
ELEV
64
DELISTED
Elevation Oncology
ELEV
$298K 0.09%
450,000
– –
ADAP
65
Adaptimmune Therapeutics
ADAP
$13.9M
$274K 0.09%
351,064
– –
MASI icon
66
Masimo
MASI
$7.43B
$263K 0.08%
3,000
– –
KPTI icon
67
Karyopharm Therapeutics
KPTI
$61.4M
$258K 0.08%
192,678
– –
CMPX icon
68
Compass Therapeutics
CMPX
$466M
$230K 0.07%
116,882
– –
NXTC icon
69
NextCure
NXTC
$13.3M
$214K 0.07%
166,185
-21,511
-11% -$27.7K
CGEN icon
70
Compugen
CGEN
$133M
$191K 0.06%
205,202
– –
SPRO icon
71
Spero Therapeutics
SPRO
$117M
$151K 0.05%
125,000
– –
KNTE
72
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$147K 0.05%
105,179
+25,000
+31% +$35K
INGN icon
73
Inogen
INGN
$213M
$78.3K 0.02%
15,000
– –
SLRN
74
DELISTED
ACELYRIN
SLRN
$74.2K 0.02%
+7,300
New +$74.2K
ISEE
75
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-612,975
Closed -$24.1M
1 2
3
4